A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Travere Therapeutics, Inc.
- Study ID
- NCT06431893
- Phase
- PHASE3
- Status
- Enrolling By Invitation
Conditions
- Homocystinuria
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Pegtibatinase — DRUGPegtibatinase BIW
Study Details
The goal of this long-term extension (LTE) study is to evaluate the safety and efficacy of pegtibatinase in patients with classical homocystinuria (HCU). Patients who are active in the Phase 1/2 COMPOSE study or those who complete the 24 weeks of blinded treatment in the Phase 3 HARMONY are eligible to participate. Participants will be in this clinical study for a minimum of 108 weeks including: * a treatment period of up to 104 weeks * a 4-week safety follow-up period
Key Dates
- Start date
- Apr 30, 2024
- Status verified
- May 2026
- Primary completion
- Aug 31, 2030
- Completion
- Aug 31, 2030
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: pegtibatinase
Primary Outcome Measure
Treatment-emergent AEs [ Time Frame: Week 1 - Week 108 ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85006 | - |
| Yale University School of Medicine | New Haven | Connecticut | 06519 | - |
| Emory University | Atlanta | Georgia | 30322 | - |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | - |
| Maine Health Pediatric Specialty Care | Portland | Maine | 04012 | - |
| Uncommon Cures | Chevy Chase | Maryland | 20815 | - |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | - |
| Science 37 - Virtual Site | Morrisville | North Carolina | 27560 | - |
| Oregon Health and Science University | Portland | Oregon | 97239 | - |
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | - |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | - |
| Utah Health - The University of Utah Primary Children's Hospital | Salt Lake City | Utah | 84113 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care TreatmentPHASE3 · Recruiting · Travere Therapeutics, Inc. · Phoenix, Arizona